Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Prima BioMed gets approval for IMP321 Phase I trial to treat solid tumours

Go Top